• SPX
  • 6032.38
  • 0.56 %
  • 33.6397
  • DJI
  • 44910.65
  • 0.42 %
  • 188.5898
  • N225
  • 38513.02
  • 0.8 %
  • 304.9883
  • FTSE
  • 8284.87
  • -0.03 %
  • -2.4297
  • IXIC
  • 19218.166
  • 0.83 %
  • 157.6895
Vaccitech plc (VACC) Stock Price, News & Analysis

Vaccitech plc (VACC) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$4.39
Day's range
$5.09
50-day range
$1.64
Day's range
$5.1
  • Country: GB
  • ISIN: US91864C1071
52 wk range
$1.64
Day's range
$5.1
  • CEO: Mr. William J. Enright MBA
  • Website: Visit Site
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 1.95
  • Piotroski Score 2.00
  • Grade Equal-Weight
  • Symbol (VACC)
  • Company Vaccitech plc
  • Price $5.00
  • Changes Percentage (11.36%)
  • Change $0.51
  • Day Low $4.39
  • Day High $5.09
  • Year High $5.10

Vaccitech plc, a clinical-stage biopharmaceutical company, engages in the discovery and development of novel T cell immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancers. The company's therapeutic programs include VTP-300, which is in Phase 1/2a clinical trial for the treatment of chronic hepatitis B infection; VTP-200 that is in Phase 1/2a clinical trial for the treatment of human papilloma virus infection; VTP-850, which is in Phase 1/2 clinical trial for the treatment of prostate cancer; and VTP-600 that is in Phase 1/2a clinical trial for the treatment of non-small cell lung cancer. Its prophylactic programs include VTP-400, which is in preclinical stage for the prevention of herpes zoster or shingles; VTP-500 that has completed Phase 1 clinical trial for the prevention of Middle East respiratory syndrome; and Vaxzevria, a prophylactic vaccine for the prevention of COVID-19 infection. The company was formerly known as Vaccitech Rx Limited and changed its name to Vaccitech plc in March 2021. Vaccitech plc was founded in 2016 and is headquartered in Oxford, the United Kingdom.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/12/2023
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.45
  • Trailing P/E Ratio -3.448275862069
  • Forward P/E Ratio -3.448275862069
  • P/E Growth -3.448275862069
  • Net Income $5.34 M

Income Statement

Quarterly

Annual

Latest News of VACC

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Vaccitech plc Frequently Asked Questions

  • What were the earnings of VACC in the last quarter?

    In the last quarter Vaccitech plc earnings were on Thursday, November, 9th. The Vaccitech plc maker reported $0.22 EPS for the quarter, beating analysts' consensus estimates of -$0.62 by $0.84.

  • What is the Vaccitech plc stock price today?

    Today's price of Vaccitech plc is $5.00 — it has increased by +11.36% in the past 24 hours. Watch Vaccitech plc stock price performance more closely on the chart.

  • Does Vaccitech plc release reports?

    Yes, you can track Vaccitech plc's financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Vaccitech plc stock forecast?

    Watch the Vaccitech plc chart and read a more detailed Vaccitech plc stock forecast to see what analysts suggest you do with its shares.

  • What is Vaccitech plc stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Vaccitech plc stock ticker.

  • How to buy Vaccitech plc stocks?

    Like other stocks, VACC shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Vaccitech plc's EBITDA?

    Vaccitech plc measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Vaccitech plc’s financial statements.

  • What is the Vaccitech plc's net income ratio for the financial year 2022?

    The net income ratio for the financial year 2022 is 0.1194998099, which equates to approximately 11.95%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Vaccitech plc stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Vaccitech plc's financials relevant news, and technical analysis. Vaccitech plc's technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Vaccitech plc stock currently indicates a “sell” signal. For more insights, review Vaccitech plc’s technical analysis.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.